If cancer treatment were cheaper and easier to administer, it would be more accessible to early-stage cancer patients across the world. That’s the reasoning behind a disposable, electronic chemotherapy patch designed by a bright group of undergrads at Harvard.
The students, under the company name Theratech, just won a $20,000 cash prize from the Create the Future design contest sponsored by COMSOL, Tech Briefs Media Group and SAE International.
At the core of their ChemoPatch is a plastic-based micropump that they say could automatically deliver up to three different chemotherapy drugs in select doses at specific time intervals.
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
Here’s how the team describes the four components of the patch in their submission:
1) a novel, patent-pending micropump for drug delivery
2) a drug reservoir that contains up to 3 separate chemotherapy drugs
3) a microneedle array for the painless administration of drugs
4) a simple microcontroller-based electronic circuit for complex programmable delivery scheduling
The current process for chemotherapy – delivered on a complex schedule from a pole-based IV pump – is part of what keeps it from being widely accessible for early-stage cancers, the team says. An automated, portable patch device could make it deliverable outside of the hospital setting.
Theratech says it’s planning to pilot the device, which has a production cost of $35 per unit, in early-stage breast cancer patients in India next year.
Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
[Image credit: Theratech/Tech Briefs]